Search clinical trials for: Beta adrenergic blockers

Total 17781 results

Indiana University
Office of Naval Research (ONR)

Completed

Mirabegron and Physiological Function in Cold Environments

Resting Energy Expenditure | Brown Adipose Tissue | Thermogenesis

United States
Korea University Anam Hospital

Active, not recruiting

Effect of Different Antihypertensive Drugs on Central Blood Pressure

Hypertension

Korea, Republic of
Astellas Pharma China, Inc.

Completed

A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants

Pharmacokinetics of Mirabegron | Food Effect | Healthy Chinese Subjects

China
Swiss Group for Clinical Cancer Research

Completed

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myeloproliferative Neoplasm

Switzerland
CHU de Quebec-Universite Laval

Completed

Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder (Mirabegron)

Overactive Bladder | Urinary Incontinence
Mercy Research
Forest Laboratories

Completed

Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function

Hypertension

United States
Astellas Pharma Inc

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder

Urinary Bladder, Overactive

Japan
AOP Orphan Pharmaceuticals AG

Completed

A Short Term Pharmacokinetic, Pharmacodynamic and Tolerability Study to Compare AOP200704 vs. Esmolol

Healthy Volunteers | Pharmacokinetics/Dynamics Study

Czech Republic
Mylan Bertek Pharmaceuticals

Completed

A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension

Hypertension

United States
Theodore R. Brown, MD MPH
Astellas Pharma Inc

Completed

Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis (MIRROR)

Multiple Sclerosis

United States
Baylor College of Medicine

Completed

Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain

Ureteral Obstruction | Flank Pain

United States
Assistance Publique - Hôpitaux de Paris
Association Française contre les Myopathies (AFM), Paris

Completed

Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy (NEBIDYS)

Heart Failure | Duchenne Muscular Dystrophy | Cardiomyopathy

France
University of California, San Diego
Forest Laboratories

Completed

Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension

Hypertension | Pre-hypertension

United States
Buddhist Tzu Chi General Hospital

Completed

Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

Urinary Incontinence | Overactive Bladder Syndrome
Astellas Pharma Inc
Astellas Pharma Taiwan, Inc.

Completed

A Study to Investigate the Safety and Effect of Food on the Pharmacokinetics of YM178 in Healthy Volunteers

Healthy Volunteer | Pharmacokinetics of YM178

Taiwan
Astellas Pharma Inc

Completed

A Study to Evaluate Absorption, Distribution and Elimination of Mirabegron After Oral Administration to Non-elderly Healthy Chinese Subjects

Healthy Subjects | Plasma Concentration of Mirabegron

Japan
Marshall University

Recruiting

Treatment of Elevated Blood Pressures in Early Pregnancy

Elevated Blood Pressure | Pregnancy Induced Hypertension

United States
Air Force Military Medical University, China

Not yet recruiting

HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients

Liver Cirrhoses | Esophageal Varices | Variceal Hemorrhage

China
Mylan Pharmaceuticals Inc

Completed

Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

Healthy

United States
Seoul National University Bundang Hospital
Chong Kun Dang Pharmaceutical Corp.

Unknown

Immediate Release Versus Slow Release Carvedilol in Heart Failure (SLOW-HF)

Heart Failure With Reduced Ejection Fraction

Korea, Republic of
Mahidol University

Completed

Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem

Hypertension | Craniotomy
Chong Kun Dang Pharmaceutical

Unknown

Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg

Essential Hypertension | Congestive Heart Failure | Chronic Stable Angina

Korea, Republic of
Medical University of Silesia

Unknown

Therapy With Verapamil or Carvedilol in Chronic Heart Failure

Dilated Cardiomyopathy

Poland
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Terminated

The Confirmatory Olmesartan Plaque Regression Study (CONFIRM)

Essential Hypertension | Carotid Plaque

Italy
Indiana University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Hypertension in Hemodialysis Patients (Aim 3)

Hypertension | Hemodialysis | Left Ventricular Hypertrophy

United States
Henning Bundgaard
Hvidovre University Hospital; Herlev Hospital; Royal North Shore Hospital; Bispebjerg-Frederiksberg... and other collaborators

Completed

Beta 3 Agonist Treatment in Heart Failure-2 (BEAT-HF II)

Heart Failure With Reduced Ejection Fraction NYHA Class III-IV

Denmark
Zonguldak Bulent Ecevit University

Completed

Changes in Cerebral Oxygenation and Cognitive Functions

Cognitive Dysfunction | Hypotension; Controlled

Turkey
Far Eastern Memorial Hospital

Withdrawn

Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome

Overactive Bladder Syndrome

Taiwan
GlaxoSmithKline

Completed

Regulatory Nebilet PMS (Nebilet PMS)

Heart Failure | Hypertension

Korea, Republic of
Seoul National University Hospital

Unknown

MIrabegron With oveRACtive bLadder Symptoms in mEn

Overactive Bladder

Korea, Republic of
AstraZeneca

Completed

Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy Men (AZD3199MAD)

Healthy Volunteers

Sweden
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)

Overactive Bladder

Poland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
Astellas Pharma Inc

Completed

Study of the Effect of Food on the Pharmacokinetics of Mirabegron

Healthy | Pharmacokinetics of Mirabegron

United States
Mylan Bertek Pharmaceuticals

Completed

A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients

Hypertension

United States
Astellas Pharma Inc
Astellas Pharma Singapore Pte. Ltd.

Completed

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Overactive Bladder

Japan, Korea, Republic of
Alcon Research

Completed

Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure

Ocular Hypertension | Open Angle Glaucoma
MedImmune LLC

Completed

Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382

Healthy Volunteers

United States
Astellas Pharma Inc

Completed

Specified Drug Use-results Survey of Betanis Tablets

Overactive Bladder

Japan
Otto Muzik

Unknown

Efficacy of Pharmacological Stimulation of BAT and WAT in Lean and Obese Young Adults (MiraBAT)

Brown Fat

United States
Astellas Pharma Inc

Completed

A Study to Investigate the Food Effect on the Pharmacokinetics of YM178 in Healthy, Non-elderly Volunteers

Healthy Volunteer | Pharmacokinetics of YM178

Japan
AstraZeneca

Completed

Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma

Asthma

Sweden
GlaxoSmithKline

Terminated

COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria

Heart Failure, Congestive and Microalbuminuria

United States, Canada, Puerto Rico
Asker & Baerum Hospital

Completed

RATe Control in Atrial Fibrillation (RATAF)

Atrial Fibrillation

Norway
Institute of Liver and Biliary Sciences, India

Recruiting

To Study the Hemodynamic Response of Early Addition of Carvedilol to Terlipressin in Acute Variceal Bleed in Child's B and C Cirrhosis

Liver Cirrhosis

India
Gitte Moos Knudsen
Danish Center for Sleep Medicine; Center for translational Neuromedicine, University...

Completed

Effects of Sleep Deprivation and Adrenergic Inhibition on Glymphatic Flow in Humans

Sleep Wake Disorders | Sleep | Sleep Deprivation

Denmark
Owen Chan, PhD

Terminated

Carvedilol in Treating Hypoglycemia Unawareness

Hypoglycemia Unawareness

United States
University of Alabama at Birmingham

Withdrawn

Mechanisms of Refractory Hypertension (Carvedilol)

Hypertensive
Federal University of Minas Gerais

Completed

A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy

Heart Failure | Chagas Cardiomyopathy | Dilated Cardiomyopathy

Brazil
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition

Fasting State

India

Search clinical trials for: Beta adrenergic blockers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations